MiniMed Group, Inc.
22.76USD
-0.5600 (-2.40%)
Revenue
| (USD) | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| FY | — | 2.5B | 2.7B | 3.1B | 3.4B | 3.7B |
| Q1 | — | — | — | 723.0M | 843.0M | — |
| Q2 | — | — | — | — | 828.4M | — |
| Q3 | — | — | 687.0M | 790.0M | 860.1M | — |
| Q4 | — | — | 724.0M* | 837.0M* | — | — |
Revenue
| (USD) | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| FY | — | -.440 | -.840 | -1.30 | .683 | .649 |
| Q1 | — | — | — | -.080 | .000 | — |
| Q2 | — | — | — | — | .122 | — |
| Q3 | — | — | -.040 | -.470 | .200 | — |
| Q4 | — | — |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
| -.680* |
| -.721* |
| — |
| — |